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The methods applied for DNA adduct determination in humans have become more reliable. Yet
there is a need to characterize the adducts studied better and, when possible, to identify them
with the help of the available standard compounds. Use of standard compounds also allows
quantification of adduct levels. There is a lack of knowledge on the adduct levels and their half-
lives in target and surrogate tissues. Most adduct studies have been carried out on occupational
populations exposed to complex mixtures. White blood cells have been the most common
source of DNA. Other exposures and tissues should be a subject of study. Notably, dietary
exposures have been largely neglected. Biomonitoring of mutations is a relatively new field and a
few exposures have so far been investigated. The results have been promising but logistics of
the studies have to be improved to make large field studies possible. Future biomonitoring
studies should make an effort to combine many end points, with emphasis on adducts, mutations,
and constitutional metabolic factors. Environ Health Perspect 105(Suppl 4):823-827 (1997)
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Introduction
Application ofDNA adducts and mutations
in human biomonitoring is recent and the
related technologies are continuously
improving. Since the 1980s when DNA
adduct studies became possible in humans
(1,2) the question about their significance
has been asked. There is no direct answer
to the question but much of circumstan-
tial evidence points to their mechanistic
role in cancer (3). Yet direct evidence is
lacking and it would be simplistic to
assume that one measurement in time
would tell much about the risk. However,
if a particular exposure has lasted for an
extended time, or if it has been excessive,
such as anticancer chemotherapy or an
accident involving exposure to radioactive
material, some increase in risk may be
predicted. Some, but by no means all, of
the reasons DNA adducts are important
are the following:
* Adducts cause mutations: e.g., con-
struction of a specific mutation in a
phage or virus leads to a specific muta-
tion at a site of adduct; DNA repair
defects.
* Mutations in viral and cellular onco-
genes, tumor suppressor genes; trans-
genic animals can cause cancer.
* Adducts, cross-links in particular, are
cytotoxic and thus mitogenic; cell pro-
liferation may contribute to cancer.
* Adducts show individual exposure,
metabolic capacity, and DNA repair
capacity.
* Adducts indicate present DNA damage
(cf. epidemiology).
* Adduct-forming chemicals-e.g., many
anticancer agents-are potentially
dangerous.
* Adducts can show active ingredients in
complex mixtures.
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Although first emphasized in the
"initiation" phase of carcinogenesis, the
recent evidence of genetic lesions in
multiple steps of cancer development,
suggests that DNA damage plays a role in
many stages of oncogenesis. Among the
available methods, only 32P-postlabeling
is discussed here because of its wide
application in the occupational and
environmental studies.
The role of mutations has not been
questioned to the same extent as that of
DNA adducts because mutations play an
important role in the development of
cancer (4). However, the appearance of
mutations in surrogate tissues of healthy
individuals may not be directly informative
ofthe events in target tissues. Additionally,
all the mutational systems available for
human biomonitoring have their own
features and limitations (5). Only one
mutational system, based on hypoxan-
thine-guanine phosphoribosyl transferase
(HPRT), is discussed here.
Development ofthe
32P-Postlabeling Method
The 32P-postlabeling method, introduced
about 15 years ago, made it possible for the
first time to analyze DNA-adducts existing
in DNA in vivo. The method has been
used extensively to compare adduct pat-
terns in various tissues and in various expo-
sures. Most studies have focused on
unidentified aromatic adducts because the
original technique selects for these types of
adducts (6). More recently, standard com-
pounds have been used in the identifica-
tion and quantification of adducts (2).
Although this is widely accepted now, it
was long thought by a large section of the
postlabeling community that labeling ofall
adducts was complete. By now it has been
demonstrated with tens of different syn-
thetic postlabeling standards that, depend-
ing on the adducts and conditions of
labeling, the recoveries vary between 0 and
100%. Even diastereomers can label differ-
ently. In an illustrative experiment, DNA
adducts of a number of 3H-labeled
polycyclic aromatic hydrocarbons (PAH)
were prepared in a microsomal system and
used for optimization and measurement
of recoveries in the postlabeling assay.
The optimal labeling conditions for all
tested compounds were very similar. The
recoveries varied from 3 to 60% among
different PAHs, indicating that the levels
of these adducts could be considerably
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underestimated in analyses of human
samples from PAH-exposed populations.
Because we have found similar results with
an entirely different group ofcompounds,
it generally can be concluded that different
adducts require different conditions for
optimal labeling (7). Thus the absence of
proper standards, or analysis of unknown
adducts, impedes quantitative interpreta-
tion ofthe postlabeling results. The most
important parameters for optimal postla-
beling are that the adduct must be known;
the standard must be synthesized and its
stability tested; the standard's labeling effi-
ciency must be tested; and the total recov-
ery of the tested DNA adduct must be
determined. Below some illustrative exam-
ples ofthe application of the postlabeling
method are given. Extensive surveys ofthe
literature are available (1,6).
Surrogate versus
Target Tissues
In biomonitoring of almost any end
point, surrogate rather than target tissues
have to be used. The information on the
applicability of surrogate tissues in
humans is scanty. In some animal experi-
ments the question of the correlation of
adducts in surrogate and target tissue has
been addressed [(8) and references
therein]. Rats were exposed by inhalation
to individual alkenes from ethene to
octene; DNA adducts in liver and lym-
phocytes and hemoglobin adducts were
measured (Figure 1). For all these adducts
the levels decreased from ethene to
octene. However, the decrease was 5-fold
in liver, 30-fold in lymphocytes, and
2000-fold in hemoglobin. This was inter-
preted as indicating a complex interplay
Ge Cs
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Figure 1. Liver and lymphocyte DNA(adducts/107 nor-
mal nucleotides) and hemoglobin N-(2-hydroxy)valine
adducts (x500 pmol/g) of rats exposed to 300 ppm of
alkenes from ethene (C2) to octene (C8) for 12 hr on 3
consecutive days (8). DNA react., reactivity of alkene
epoxides with DNA in vitro; Hb, hemoglobin.
oftissue uptake, metabolism, and diffusion
out oforgans.
In humans, smoking has been the main
model of exposure used. Smoking is a
known risk factor oflaryngeal cancer. Aro-
matic adducts oflaryngeal tissue obtained
from surgery patients were analyzed and a
relationship to smoking was found. Both
tumor and normal laryngeal tissues showed
a correlation ofabout 0.9 to the total white
blood cells (9).
Tobacco smoke contains methylating
and hydroxyethylating principles, originat-
ing, for example, from tobacco-specific
nitrosamines and ethene, respectively. The
levels of 7-methylguanine were highest in
the bronchial DNA ofsmokers, exceeding
the level in nonsmokers by almost 4 times
(10). In a small number ofsmokers, both
target (bronchial) and surrogate (lympho-
cyte) DNA were available, showing a cor-
relation of 0.8. [We now know that the
7-methylguanine adduct spot also contains
7-(2-hydroxyethyl)guanine adducts, which,
however, were poorly labeled and con-
tributed little to the radioactivity of the
spot (11)]. Larynx tissue samples obtained
from surgery patients were also assayed
for 7-methylguanine DNA adducts.
There was a relationship to smoking, and
larynx adduct levels exceeded those of
white blood cells by twice (12). There was
a modest correlation only between 7-alkyl-
guanines and aromatic adducts (above).
The smokers had higher aromatic adduct
levels in lymphocytes than in granulocytes,
which indicated that in chronic exposure
the main focus should be on lymphocytes
(13). Smokers also had elevated levels of
7-methylguanine, particularly in their lym-
phocytes as compared to the granulocyte
DNA (14). However, taking into consider-
ation the very different half-lives of lym-
phocytes and granulocytes, the isolation of
cells only clears away the "noise" caused by
granulocytes and improves the precision, as
only about 25% ofthe DNA in total white
blood cells is from lymphocytes. This
should be an important principle applied
in biomonitoring studies.
Aromatic Adducts
In spite ofproblems in interpretation of
postlabeling results ofcomplex mixtures,
most published literature concerns expo-
sures in which PAHs are of primary con-
cern. Many of the groups studied have
been at risk of cancer according to epi-
demiological reports that reflect exposures
a few decades ago. The main questions
posed have been: a) do the exposed groups
show higher, work-related adduct levels
than the controls; b) is there a correlation
between exposure measures (air concentra-
tion or urinary 1-hydroxypyrene) and
adducts; and C) how large are the individ-
ual variations and metabolic genotypes on
the level ofadducts?
Occupational Populations
The study populations have included
foundry and coke workers, aluminum and
electrode workers, and chimney sweeps.
Additionally, some other occupational
groups have been studied as reference
groups in environmental studies, discussed
below. Examples are given on some collab-
orative studies in which our laboratory has
participated. The foundry study has
involved blood and urine sampling of the
same individuals each December for four
years. The last sampling was done in
December 1993. It is a multi-end point
study, including some 15 parameters. Only
results from the first 2 years on certain out-
comes have been published but an intense
compilation ofthe total material is under-
way. The first published papers showed
elevated total white blood cell DNA
adduct levels as measured by immunoassay
(15) and postlabeling (16,17), relating to
exposure. Among the other occupational
groups, coke workers had higher levels of
aromatic adducts than the local controls
(18,19). Somewhat elevated but not statis-
tically significant differences were seen in
electrode and aluminum workers even
though air concentrations of PAHs and
urinary 1-hydroxypyrene levels indicated
excessive exposure (20,21). Adduct levels
were also slightly increased in total white
blood cell DNA of chimney sweeps.
However, the difference to a control group
became significant only after adjustment
for the CYPIAJ and glutathione S-trans-
ferase (GSTMI) genotype (22). Yet each
of the genotypes alone had a rather small
effect on DNA adduct levels. In all the
studies cited, the interindividual variation
in the levels ofadducts has been large, over
10-fold. The variation is usually larger in
the exposed than in the control popula-
tions, suggesting that exposures as well as
constitutional factors contribute to such
a variation.
EnvironmentailyExposedPopulations
Two series ofenvironmental studies have
been conducted, one in Poland and the
other mainly in Sweden. The Polish study
was initiated several years ago in response
to the alarming reports of environmental
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pollution in Silesia, a heavily industrialized
area. The first study on the Silesian popula-
tion showed an elevated level ofadducts,
by postlabeling and immunoassay, in the
total white blood cells of the residents
(23). This was followed by reports ofsea-
sonal differences in adduct levels, which
matched the air concentrations of PAHs
(18,24). The effects were mainly seen in
DNA ofthe long-lived lymphocytes, while
granulocytes showed no clear effect.
Sampling in both summer and winter
allowed a rough estimation ofthe half-lives
ofaromatic adducts in lymphocytes of 1 to
2 months (24). Also, cytogenetic damage
was seen in the Silesian population (25).
The nature ofthe adducts detected by
postlabeling has been studied in more detail
by comparing nuclease P1, butanol extrac-
tion, and immunoaffinity purification of
the adducts. Adduct recovery was approxi-
mately equal by the P1 and butanol tech-
niques, suggesting that the adducts are
of PAH-type. For immunoaffinity chro-
matography an antibody raised against
benzo[a]pyrene diol epoxide-DNA was
used. Only about 25% ofthe adducts were
bound by the antibody, indicating that
most ofthe adducts in DNA are not dosely
related to benzo[a]pyrene. However, in
winter, a time ofhigh air pollution, the rel-
ative binding by the immunoaffinity col-
umn was higher than in the summer (19).
In HPLC analysis using flow-through
radioactivity detectors, typical seasonal
adduct peaks were noted and theywere par-
ticularly prominent in lymphocyte DNA
collected in the winter. They eluted in the
area of PAH-DNA adducts, giving addi-
tional support to the conclusion that the
adducts are PAH-like (Figure 2) (26).
A study of bus drivers from central
Stockholm and from the city's outskirts
compared these subjects to a nonoccupa-
tional control group offine mechanics. All
participants were nonsmokers. Aromatic
DNA adducts in lymphocytes, PAH
adducts in albumin and ethene, and
propene adducts in hemoglobin were not
elevated in the urban bus drivers (27). A
similar type of study was conducted in
Milan, Italy. The studysubjects were news-
paper vendors from busy streets and from
the outskirts ofMilan. The levels of DNA
adducts did not differ in these populations.
Some occupational groups, exposed to
car and diesel exhaust, were positive con-
trols in the above study. They included
garage workers who overhauled diesel
buses and inhaled diesel exhaust gases, car
mechanics exposed to spilled engine oils
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Figure 2. Aromatic adduct levels of a typic
ing man from Silesia as analyzed by HPLC
lymphocytes collected in the winter was;
the peaks numbered in the order of elution
numerals refer to elution of some sta
adducts of PAHs (26).
but not to exhaust, and truck
workers, unloading and rtloadi
trucks. All these groups had i
levels of lymphocyte DNA add
highest levels being correlated
concentrations ofdiesel exhausts.
mated air benzo[a]pyrene leN
below 10 ng/m3 (28). GSTM
acetyltransferase (NAT2) genot)
determined in the study subjects
viduals with a combined genotyF
acetylation but lacking the GST
the adduct levels were sign
increased (29). Neither genoty
had an effect on the level ofaddu
Styrene
Genotoxicity ofstyrene has been
worldwide because it is one ofth
pected mutagenic compounds
cause daily exposures in gram c
(30). Styrene is an example of
chemical characterization, fasci
itself, leads to production of
compounds for postlabeling (31,
quantification of 06-guanine a
white blood cell DNA of lan
workers (32). Further studies b
carried out to sample the same
tion workers periodically in orde
sure lymphocyte and granulocy
Again it was shown that adducts
tially only found in lymphoc)
repair of 06-adducts appeared tc
since no essential decrease in add
was noted after workers took
vacation (33).
Ki The adduct studies suggested that the
xnl factory controls, in fact, are not completely
unexposed. Strand breaks, measured by the
Comet assay, were also increased in the
lamination workers. There was a correlation
between strand breaks and 06-guanine
adducts, but neither correlated with HPRT
mutant frequency (34). In vitrodata on the
13 effect ofstyrene oxide (the main metabolite
of styrene) on cultured human lympho-
cytes confirmed the relatively long half- 1415 lives of 06-guanine DNA adducts and the 16 induction ofstrand breaks (35).
70 80 HPRTMutations
Mutations in the HPRTgene in human
lymphocytes have been studied extensively,
al nonsmok- but only a few occupational studies and, as
C DNA from far as we know, no environmental studies assayed and on chemical exposures have been carried
ndard DNA out (5). The nonoccupational studies
include those on smoking-, radiation-,
chemotherapy-, and disease-induced muta-
tion rates. The limited number ofoccupa-
terminal tional studies partially reflects logistic
ing diesel problems because cell separation from
increased blood has to be carried out within hours of
lucts, the blood collection, and living cells have to be
with air delivered to the analyzing laboratory.
The esti- Moreover, large interindividual differences
vels were and dependence of the mutation rates on
I and N- age and smoking may discourage attempts
ypes were to distinguish small differences between
i. In indi- the exposed and control populations.
)e ofslow Among the occupational groups studied,
Ml gene, workers producing the anticancer agent
ificantly cyclophosphamide have elevated levels
ype alone of lymphocyte HPRTmutations (36).
Lcts. Exposures to ethylene oxide (37) and
styrene/dichloromethane have also caused
increases in mutation frequency (38). In
ofinterest our studies on lamination workers (above)
e few sus- the HPRTmutation frequency was ele-
that may vated in workers exposed to styrene but the
quantities increase reached statistical significance only
'how the when compared to an external rather than
Lnating in an in-house, factory control group (34).
standard Induction of HPRTmutations in cultured
) and to a human lymphocytes exposed to styrene
dducts in oxide was considered weak (35).
nination We have also measured mutant fre-
iave been quencies in occupational populations
e lamina- exposed to PAHs. In the foundry study,
.r to mea- HPRTcorrelated with exposure and adduct
rte DNA. levels, while glycophorin A NO mutations
are essen- had a moderate, but statistically not signifi-
ytes. The cant trend with exposure (16,17). The
be slow, HPRTmutant frequency was not increased
[uct levels in garage workers, but at an individual level
a 2-week there was a highly significant correlation
between adducts and mutant frequency
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Figure 3. Aromatic DNA adduct levels of workers
exosed to diesel exhaust(28) as related to HPRTmuta-
tion frequency in peripheral lymphocytes (29). The cor-
relation for the total study population, as shown in the
figure, or for the exposed workers was approximately
0.35. MF, mutant frequency.
(r-0.35), shown in Figure 3. GSTMI and
NAT2 genotypes were determined in the
study subjects. The genotypes, alone or
combined, had no effect on HPRTmutant
frequency (29).
Conclusions
Biomonitoring by means ofDNA adducts
or mutations must meet requirements of
technical validity and unbiased selection
and comparison ofthe study populations.
Although individual studies have demon-
strated technical reproducibility, a limited
number of interlaboratory studies have
been conducted (1,5). The study popula-
tions have often been small and selected by
easy availability rather than by compara-
bility. The elementary requirement of
assaying coded samples has frequently
been neglected.
DNA adduct studies in humans are
becoming more quantitative and therefore
offer chances for quantitative risk esti-
mation. Since epidemiological studies
always show the risks ofexposure decades
back, DNA adduct studies can be used
for current risk estimation. DNA adduct
studies are likely to give clues to individ-
ual risks and may therefore be useful in
protecting sensitive populations. Assays of
point mutations, such as those in the
HPRTlocus have been used to a limited
extent in biomonitoring of chemical
exposure. The studies published so far are
promising. Mutations as compared to
DNA adducts are mechanistically closer to
the cancer end point and would provide a
valuable addition to risk assessment of
chemical exposures.
REFERENCES
1. IARC. Postlabelling Methods for Detection of DNA Adducts
(Phillips DH, Castegnaro M, Bartsch H, eds). IARC Scientific
Publications No 124. Lyon:International Agency for Research
on Cancer, 1993.
2. IARC. DNA Adducts: Identification and Biological
Significance (Hemminki K, Dipple A, Shuker DEG, Kadlubar
FF, Segerback D, Bartsch H, e[s). [ARC Scientific Publications
No 125. Lyon:International Agency for Research on Cancer,
1994.
3. Hemminki K. DNA adducts, mutations and cancer.
Carcinogenesis 14:2007-2012 (1993).
4. Vainio H, Magee P, McGregor D, McMichael AJ (eds). [ARC
Scientific Publications No 116. Lyon:International Agency for
Research on Cancer, 1992.
5. Cole J, Skopek RT. Somatic mutation frequency, mutation
rates and mutational spectra in the human population. Mutat
Res 304:33-105 (1994).
6. Hemminki K. DNA adducts in biomonitoring. J Occup
Environ Med 37:44-51 (1995).
7. Kumar R, Staffas J, Forsti A, Hemminki K. 32P-postlabelling
method for the detection of7-alkylguanine adducts formed by
the reaction of different 1,2-alkyl epoxides with DNA.
Carcinogenesis 16:483-489 (1995).
8. Eide I, Hagemann R, Zahlsen K, Tareke E, T6rnqvist M,
Kumar R, Vodicka P, Hemminki K. Uptake, distribution, and
formation ofhemoglobin and DNA adducts after inhalation of
C1-C8 1-alkenes (olefins) in the rat. Carcinogenesis
16:1603-1609 (1995).
9. Szyfter K, Hemminki K, Szyfter W, Szmeja Z, Banaszewski J,
Yang K. Aromatic DNA adducts in larynx biopsies and leuco-
cytes. Carcinogenesis 15: 2195-2199 (1994).
10. Mustonen R, Schoket B, Hemminki K. Smoking-related DNA
adducts: 32P-postlabeling analysis of 7-methylguanine in
human bronchial and lymphocyte DNA. Carcinogenesis
14:151-154 (1993).
11. Kumar R, Hemminki K. Separation of 7-methyl and 7-(2-
hydroxyethyl)-guanine adducts in human DNA samples using
a combination ofTLC and HPLC. Carcinogenesis 17:485-492
(1996).
12. Szyfter K, Hemminki K, Szyfter W, Szmeja Z, Banaszewski.
Tobacco smoke-associated N7-alkylguanine in DNA oflarynx
tissue and leucocytes. Carcinogenesis 17:501-506 (1996).
13. Savela K, Hemminki K. DNA adducts in lymphocytes and
ranulocutes of smokers and nonsmokers detected by the §2P-posdabeling assay. Carcinogenesis 12:503-508 (1991).
14. Mustonen R, Hemminki K. 7-Methylguanine levels in DNA of
smokers and non-smokers' total white blood cells, granulocytes
and lymphocytes. Carcinogenesis 13:1951-1955 (1992).
15. Santella R, Hemminki K, Tang D, Paik M, Ottman R, Young
TL, Savela K, Vodickova L, Dickey C, Whyatt R et al.
PAH-DNA adducts in white blood cells and urinary 1-
hydroxypyrene in foundry workers. Cancer Epidemiol
Biomarkers Prev2:59-62 (1993).
16. Perera FP, Tang DL, O'Neill JP, Bigbee WL, Albertini RJ,
Santella R, Ottman R, Tsai WY, Dickey C, Mooney LA et al.
HPRTand glycophorin A mutations in foundry workers: rela-
tionship to PAH exposure and to PAH-DNA adducts.
Carcinogenesis 14:969-973 (1993).
17. Perera FP, Dickey C, Santella R, O'Neill JPO, Albertini,RJ,
Ottman R, Tsai WY, Mooney LA, Savela K, Hemminki K.
Carcinogen-DNA adducts and gene mutation in foundry work-
ers with low-level exposure to polycyclic aromatic hydrocar-
bons. Carcinogenesis 15:2905-2910 (1994).
18. Grzybowska E, Hemminki K, Chorazy M. Seasonal variations
in levels of DNA adducts and X-spots in the human popula-
tions living in different parts of Poland. Environ Health
Perspect 99:77-81 (1993).
19. Widlak P, Grzybowska E, Hemminki, K, Santella R, Chorazy
M. 32P-Postlabelling ofbulky human DNA adducts enriched
by different methods including immunoaffinity chromatogra-
phy. Chem Biol Interact 99:99-107 (1996).
20. Ovrebo S, Haugen A, Hemminki K, Szyfter K. Biological mon-
itoring ofexposure to polycyclic aromatic hydrocarbon in an
electrode paste plant. J Occup Med 36:303-310 (1994).
21. Ovrebo S, Haugen A, Hemminki K, Szyfter K, Drablos PA,
Skogland M. Studies ofbiomarkers in aluminum workers occu-
pationally exposed to polycyclic aromatic hydrocarbons. Cancer
Detect Prev 19:258-267 (1995).
22. Ichiba M, Hagmar L, Rannug A, Hogstedt B, Alexandrie A-K,
Carstensen U, Hemminki K. Aromatic DNA adducts,
micronuclei and genetic polymorphism for CYPIAJ and GSTI
in chimney sweeps. Carcinogenesis 15:1347-1352 (1994).
23. Hemminki K, Grzybowska E, Chorazy M, Twardowska-
Saucha K, Sroczynski JW, Putman KL, Randerath K, Phillips
826 Environmental Health Perspectives * Vol 105, Supplement 4 a June 1997ADDUCTS AND MUTATIONS
DH, Hewer A, Santella RM et al. DNA adducts in humans
environmentally exposed to aromatic compounds in an indus-
trial area ofPoland. Carcinogenesis 11:1229-1231 (1990).
24. Grzybowska E, Hemminki K, Szeliga J, Chorazy M. Seasonal
variation ofaromatic adducs in human lymphocytes and granu-
locytes. Carcinogenesis 14:2523-2526 (1993).
25. Perera FP, Hemminki K, Grzybowska E, Motykiewicz G,
Michalska J, Santella R, Young T-L, Dickey C, Brandt-RaufP,
DeVivo I et al. Molecular damage from environmental pollu-
tion in Poland. Nature 360:256-258 (1992).
26. M6ller L, Grzybowska E, Zeisig M, Cimander B, Hemminki
K, Chorazy M. Seasonal variation of DNA adduct patterns in
human lymphocytes analyzed by 32P-HPLC. Carcinogenesis
17:61-66 (1996).
27. Hemminki K, Zhang LF, Kruger J, Autrup H, Tornqvist M,
Norbeck HE. Exposure ofbus and taxi drivers to urban air pol-
lutants as measured by DNA and protein adducts. Toxicol Lett
72:171-174 (1994).
28. Hemminki K, Soderling J, Ericson P, Norbeck HE, Segerback
D. DNA adducts among personnel servicing and loading diesel
vechicles. Carcinogenesis 15:767-769 (1994).
29. Hou S-M, Lambert B, Hemminki K. Relationship between
hprtmutant frequency, aromatic DNA adducts and genotypes
for GSTMI and NAT2 in bus maintenance workers.
Carcinogenesis 16:1913-1917 (1995).
30. Hemminki K, Vodicka P. Styrene: from characterisation of
DNA adducts to application in styrene-exposed lamination
workers. Toxicol Lett 77:153-161 (1995).
31. Vodicka P, Hemminki K. 32P-postlabeling ofN-7, N2 and 06
2'-deoxyguanosine 3'-monophosphateadlucts ofstyrene oxide.
Chem Biol Interact 77:39-50 (1991).
32. Vodicka P, Vodickova L, Hemminki K. 32P-postlabelling of
DNA adducts of styrene-exposed lamination workers.
Carcinogenesis 14:2059-2061 (1993).
33. Vodicka P, Vodickova L, Trejbalova K, Sram RJ, Hemminki K.
Persistence of 06-guanine DNA adducts in styrene-exposed lam-
ination workers determined by 32P-postlabelling. Carcinogenesis
15:1949-1953 (1994).
34. Vodicka P, Bastlova T, Vodickova L, Peterkova K, Lambert B,
Hemminki K. Biomarkers ofstyrene exposure in lamination
workers: levels of06-guanine DNAadducts, DNAstrand brakes
and mutant frequencies in the hypoxanthine-guanine phosphori-
bosyltransferase gene in T-lymphocytes. Carcinogenesis
16:213-216 (1995).
35. Bastlova T, Vodicka P, Peterkova K, Hemminki K, Lambert B.
Styrene oxide-induced HPRTmutations and DNA strand
breaks in cultured human T-lymphocytes. Carcinogenesis
16:2357-2362 (1995).
36. Huttner E, Mergner U, Braun R, Schoneich J. Increased fre-
quency of6-thioguanine-resistant lymphocytes in peripheral
blood ofworkers employed in cyclophosphamide production.
Mutat Res 243:101-107 (1990).
37. Tates AD, Grummt T, T6rnqvist M, Farmer PB, van Dam FJ,
van Mossel H, Schoemaker HM, Osterman-Golkar S, Uebel C,
YangYS et al. Biological and chemical monitoring ofoccupational
exposure to ethylene oxide. Mutat Res 250:483497 (1991).
38. Tates AD, Grummt T, van Dam FJ, de Zwart F, Kasper FJ,
Rothe R, Stirn H, Zwinderman AH, Natarajan AT.
Measurement offrequencies of HPRTmutants, chromosomal
aberrations, micronuclei, sister-chromatid exchanges and cells
with high frequency of SCEs in styrene/dichloromethane-
exposedworkers. Mutat Res 313:249-262 (1994).
Environmental Health Perspectives * Vol 105, Supplement 4 * June 1997 827